Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy? [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
Tempus AI TEM and Doximity DOCS stand out as emerging players in the AI health tech space. These two offer distinct approaches to innovation and market disruption. Tempus AI is focused on leveraging AI-driven precision medicine, particularly in oncology and chronic disease management, while Doximity operates as a digital platform connecting medical professionals with tools for communication, telehealth and workflow efficiency. With both companies showing promise, the question arises: which stock is the better buy at this moment? Let's delve deeper. Revenue and Margins Expanding Together: Tempus AI ended 2024 on a high note, posting 35.8% year-over-year revenue growth in the fourth quarter. Even more impressive was the fact that its gross profit rose 49.7%, highlighting improving operational leverage. Its high-margin Data and Services business gained traction, supported by a 140% net revenue retention rate and $940 million in remaining contract value. Management sees this margin mo
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- The Greatest Value From AI Scribes May Come From Influencing Decisions, Not Documenting Them [Forbes]Forbes
- Doximity (NASDAQ:DOCS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Doximity (NASDAQ:DOCS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.MarketBeat
- Doximity (DOCS) Q2 2026 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why Is Doximity (DOCS) Stock Soaring Today [Yahoo! Finance]Yahoo! Finance
DOCS
Earnings
- 11/6/25 - Beat
DOCS
Sec Filings
- 12/3/25 - Form 4
- 12/1/25 - Form 144
- 11/24/25 - Form 4
- DOCS's page on the SEC website